Furthermore, other evidence showed the presence of SARS-CoV-2 IgA and IgG antibodies in the breastmilk of COVID-19 recovered women, raising the possibility that these antibodies could provide specific immunologic benefits to breastfeeding infants and provide protection against virus transmission [19,20]. The gene discussed is CD79A; the disease is COVID-19.